CL 218872 is a nonbenzodiazepine sedative and hypnotic compound that functions as a partial agonist at GABAA receptors, showing specific selectivity for the α1 subunit. Beyond its primary role as a research… Read more
CL 218872 is a nonbenzodiazepine sedative and hypnotic compound that functions as a partial agonist at GABAA receptors, showing specific selectivity for the α1 subunit. Beyond its primary role as a research tool for investigating sedative, anxiolytic, and anticonvulsant activities, this agent is frequently employed in studies exploring the mechanisms of neurotransmission and receptor-ligand interactions. To support rigorous scientific investigation, our range of related compounds includes high-quality reference standards, metabolites, and stable isotope labelled versions of the parent molecule. These specialized products are essential for precise analytical testing and method validation within pharmaceutical research and development. By facilitating accurate impurity profiling and quantitative assessment, these materials help researchers maintain stringent quality control standards when evaluating the pharmacodynamics and chemical stability of CL 218872 in experimental settings.